This slide was prepared for teaching purpose to medical students. It contain information from different books and medical journals. please inform if any of the information given need to be changed.
This slide was prepared for teaching purpose to medical students. It contain information from different books and medical journals. please inform if any of the information given need to be changed.
Dr Abdullah Ansari
PG-2 (Medicine)
AMU ALIGARH
A general approach to periodic paralysis....
(including hypokalemic periodic paralysis and thyrotoxic periodic paralysis, and other “Channelopathies” or “Membranopathies)
Pathophysiology
Epidemiology
Primary or familial periodic paralysis
Secondary periodic paralysis
Conventional classification of periodic paralysis
Classification of primary periodic paralysis based on ion-channel abnormalities
Clinical approach to a case of periodic paralysis
History of muscle weakness
Age of onset
Family history
Timing
Intensity
History of administration of certain drugs
Clinical examination
Differential Diagnosis
Laboratory investigations
Serum K+
CPK and serum myoglobin
ECG
EMG
Nerve conduction studies
Provocative Testing
Muscle biopsy
Treatment
Prognosis
Massive Splenomegaly By Dr Bashir Ahmed Dar Chinkipora Sopore Kashmir Associa...Prof Dr Bashir Ahmed Dar
Dr.Bashir Ahmed Dar Chinkipora Sopore Kashmir India,Associate Prof of medicine presently working in malaysia is a keen teacher, educator and takes pride in his clinical and research accomplishments. His interests include publishing articles related to health issues.Email drbashir123@gmail.com
Dr Abdullah Ansari
PG-2 (Medicine)
AMU ALIGARH
A general approach to periodic paralysis....
(including hypokalemic periodic paralysis and thyrotoxic periodic paralysis, and other “Channelopathies” or “Membranopathies)
Pathophysiology
Epidemiology
Primary or familial periodic paralysis
Secondary periodic paralysis
Conventional classification of periodic paralysis
Classification of primary periodic paralysis based on ion-channel abnormalities
Clinical approach to a case of periodic paralysis
History of muscle weakness
Age of onset
Family history
Timing
Intensity
History of administration of certain drugs
Clinical examination
Differential Diagnosis
Laboratory investigations
Serum K+
CPK and serum myoglobin
ECG
EMG
Nerve conduction studies
Provocative Testing
Muscle biopsy
Treatment
Prognosis
Massive Splenomegaly By Dr Bashir Ahmed Dar Chinkipora Sopore Kashmir Associa...Prof Dr Bashir Ahmed Dar
Dr.Bashir Ahmed Dar Chinkipora Sopore Kashmir India,Associate Prof of medicine presently working in malaysia is a keen teacher, educator and takes pride in his clinical and research accomplishments. His interests include publishing articles related to health issues.Email drbashir123@gmail.com
This slides contains all you need to know about "Status Epilepticus" in a nutshell. It includes definition, investigation, emergency management of status epilepticus. This educational material is suitable for med students, paramedics, nurses & neurology residents.
Template made for case presentation; by Ali Abdallah, student in the last class of school of medicine in University of Slemani,Practicing in Sulaimaniyah teaching hospital.
Flu Vaccine Alert in Bangalore Karnatakaaddon Scans
As flu season approaches, health officials in Bangalore, Karnataka, are urging residents to get their flu vaccinations. The seasonal flu, while common, can lead to severe health complications, particularly for vulnerable populations such as young children, the elderly, and those with underlying health conditions.
Dr. Vidisha Kumari, a leading epidemiologist in Bangalore, emphasizes the importance of getting vaccinated. "The flu vaccine is our best defense against the influenza virus. It not only protects individuals but also helps prevent the spread of the virus in our communities," he says.
This year, the flu season is expected to coincide with a potential increase in other respiratory illnesses. The Karnataka Health Department has launched an awareness campaign highlighting the significance of flu vaccinations. They have set up multiple vaccination centers across Bangalore, making it convenient for residents to receive their shots.
To encourage widespread vaccination, the government is also collaborating with local schools, workplaces, and community centers to facilitate vaccination drives. Special attention is being given to ensuring that the vaccine is accessible to all, including marginalized communities who may have limited access to healthcare.
Residents are reminded that the flu vaccine is safe and effective. Common side effects are mild and may include soreness at the injection site, mild fever, or muscle aches. These side effects are generally short-lived and far less severe than the flu itself.
Healthcare providers are also stressing the importance of continuing COVID-19 precautions. Wearing masks, practicing good hand hygiene, and maintaining social distancing are still crucial, especially in crowded places.
Protect yourself and your loved ones by getting vaccinated. Together, we can help keep Bangalore healthy and safe this flu season. For more information on vaccination centers and schedules, residents can visit the Karnataka Health Department’s official website or follow their social media pages.
Stay informed, stay safe, and get your flu shot today!
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
Anti ulcer drugs and their Advance pharmacology ||
Anti-ulcer drugs are medications used to prevent and treat ulcers in the stomach and upper part of the small intestine (duodenal ulcers). These ulcers are often caused by an imbalance between stomach acid and the mucosal lining, which protects the stomach lining.
||Scope: Overview of various classes of anti-ulcer drugs, their mechanisms of action, indications, side effects, and clinical considerations.
2. Definition
Seizure: Is a paroxysmal event due to transient, abnormal, excessive, hyper-
synchronous discharges from an aggregate of CNS neurons; characterized by
disturbance in muscle tone, posture, sensation, consciousness, or
psychological state.
Convulsion: Is seizure with abnormal movement.
Epilepsy: syndrome due to recurrent unprovoked seizures;
it’s diagnosed when there are two or more unprovoked
seizures due to a chronic, underlying process.
Approach: Ideas or actions intended to deal with a problem or situation.
“WordWeb dictionary”
3. ClassificationofSeizure
This is essential for diagnosis, therapy, and prognosis.
Focal S. Vs. generalized S.
Febrile S. Vs. non febrile S.
Epileptic S. Vs. non epileptic S.
True S. Vs. pseudo S.
6. Approach
History from and description by an eye witness is the main line of diagnosis.
History of the patient about seizure manifestations may give clue about type and location
of the seizure focus.
Questions:
- Whether, it’s initial onset, or he/she had attacks which was overlooked by the parents?
- Nature and pattern (clustering) of the attack.
- Precipitating factor: (sleep or sleep deprivation, TV, stress, mental activity) or
exacerbations.
- Frequency, duration and time of occurrence.
- History of personality change or symptoms of raised ICP intracranial tumor; versus
history of cognitive regression degenerative or metabolic disorder.
- Certain medications such as CNS stimulants and antihistamines.
- History of prenatal and perinatal distress or developmental delay cong. Or perinatal
brain dysfunction
- Including family history of epilepsy and febrile convulsion.
- History of postictal period.
7. Approach
History :
Age may lead you to the cause or even the type of the seizure:
– Neonate (<1 month): Hypoxia, CNS infection, metabolic, drug
withdrawal, developmental and genetic disorders.
– Infants and children (<12 years): Febrile, genetic, CNS infection,
trauma and idiopathic.
– Adolescent and young adults (13-35): Trauma, alcohol withdrawal,
drugs, tumor, idiopathic.
– Older adults (>35): Cerebrovascular disease (50%), tumor, alcohol
withdrawal, metabolic, Idiopathic.
Abnormal movements:
o Present: Grand-mal, Tonic, Clonic, ...
o Absent: petit-mal, atonic, …
Eye rolling: Absence of eye rolling increase suspicion of non-convulsive causes of LOC.
Duration: significance and even type of the attack.
8. Physical Examination:
General exam includes:
– Vital signs and respiratory and cardiac function.
– Search for signs of infection, trauma, toxins, systemic
illness, neurocutaneous abnormalities, vascular disease
and drugs.
Asymmetries in neurologic exam suggest brain
tumor, stroke, trauma, or other focal lesions.
Skin exam for pigmented or de-pigmented spots .
Approach
9. Investigations:
Laboratory Evaluation:
Blood exam: for CBC, electrolytes, serum glucose,
liver and renal function, urinalysis, toxicology screen
and culture.
Lumbar puncture: indicated if suspicion of CNS
infection (when meningeal signs present),
mandatory in HIV-infected patients.
Approach
10. Acute Management:
A. Non-Specific:
Admission
Positioning: Semi prone with head to side to avoid aspiration
ABC and normalization of vital signs
- Tongue blades should not be forced between clenched teeth
- Oxygen should be given via face mask.
Blood taken for: RBS, CBC, electrolyte, urea, Cr, lactate,
anticonvulsant level
Reversible metabolic disorders (suspected or proofed) such as:
(hypoglycemia, hypo/hyper natraemia, hypocalcaemia, drug or
alcohol withdrawal) should be corrected.
Approach
11. Acute Management:
B. Specific: Anticonvulsant therapy
* When to START …?
1. Diazepam 0.2-0.3mg/kg IV slowly; if not responds, repeat after
10 minutes; then if not responds …
2. Phenobarbital or phenytoin 10-20 mg/kg; if not responds, repeat
after 10 minutes; then if not responds …
3. Diazepam infusion, IV medazolam
4. IV Valproic acid
5. GA by pentothal, halothane with muscle relaxant under
ventilator.
C. Further investigations to detect the cause: … …
Approach
12. Approach
Investigations:
• EEG: All patients should have it as soon as possible; Ictal,
postictal abnormality, spikes and waves especially for
epileptic seizures, with provocation by photo stimulation,
sleep induction, hyperventilation. Presence of electrographic
seizure esp. during seizure attacks establish the diagnosis, But
negative EEG does not exclude diagnosis of seizure.
• E.E.G. with simultaneous closed video-recording: can provide
information which rarely records during routine E.E.G.
• Neuro-imaging CT scan & MRI: in unexplained new onset
seizure, but not used routinely.
13. Approach
Differential Diagnosis: Includes a long list, but
the main DDx. are syncope and pseudo-seizure:
1. Breath holding attacks.
2. GERD (sandifire syndrome).
3. Infantile colic.
4. Temper tantrum.
5. Masturbation in female toddlers.
6. Hysterical (conversional disorder).
7. Tics.
8. Others ……
14. Long term therapy includes:
- treatment of underlying condition
- avoidance of precipitating factors
- prophylaxis with antiepileptic therapy
- or surgery,
- and even addressing various psychological and social issues.
Choice of anti epileptic medication based on different factors including:
- Age and sex
- type of seizure
- dosing schedule
- and potential side-effects.
Therapeutic goal:
– complete cessation of seizures
– With minimal side effects
– Using single medication (mono-therapy)
– Dosing schedule that’s easy for the pt. to follow
Approach
15. Start Low, Go Slow
If ineffective, medication should be increased to maximal tolerated
dose based primarily on clinical response rather than serum level.
If unsuccessful, second drug should be added, when control achieved,
the first drug can be slowly tapered.
Some may require poly-therapy
Certain epilepsy syndromes (e.g.: temporal lobe epilepsy) are often
refractory to medical Rx. and benefits from surgical excision of the
epileptic focus.
Approach
17. Status Epilepticus
Classical definition:
- continuous seizure activity
- or two or more seizures
- in 30 minutes without recovery of consciousness.
Controversial new definition:
- more than 5 minutes of seizure activity
- or two or more seizures without recovery of consciousness.
• Status epilepticus is the most disastrous attack of seizure on the
whole life of the baby if not treated early.
• A neurological emergency with 10-20% mortality
• Treatment protocol of Status epilepticus is crucial even the timings.
18. Status Epilepticus
SE may be Convulsive with tonic/clonic movements or Non-
Convulsive with LOC and often subtle twitching.
Non-Convulsive SE is diagnosed by EEG, and suspected in comatose.
Common causes of childhood SE:
(fever, sub-theraputic anticonvulsant Rx., CNS infection, trauma,
poisoning and metabolic abnormalities)
Investigations:
19. Status Epilepticus
Time bounded algorithm for management of SE; this can be started
once a convulsive seizure has lasted more than 5 minutes:
A. 0-5 minutes: ABC
Establish IV access.
Monitor vital signs (esp. pulse oximetry)
Give 100% Oxygen via mask.
B. 5-15 minutes: Start anticonvulsant
IV lorazepam (50-100mcg/kg, up to 4mg); Or
Rectal diazepam (0.5mg/kg, up to 10mg)
If no response, repeat after 5-10 minutes
C. 15-35 minutes: if persists
IV phenytoin (15-20mg/kg, rate <1mg/kg/min)
IV Phenobarbital (15-20mg/kg, rate <1mg/kg/min)
20. Status Epilepticus
D. 45 minutes: Refractory seizure
IV phenytoin or phenobarbital (whichever was not given)
Additional phenobarbital (5mg/kg/dose, every 30min. to
maximum of 30mg/kg can be used)
If seizure stops, continue with maintenance phenytoin
(IV/oral/via NG)
Refractory seizure: Intensive care:
If seizure persists, intensive care should be initiated
Intubate the trachea and support breathing
Intensive care medications include midazolam and thiopentone
EEG monitoring
21. Prognosis
Generally excellent:
• Idiopathic
• Hypocalcemia
• Benign familial neonatal seizure
• Fifth-day fit
Significant risk of adverse neurodevelopmental outcome
• Meningitis
• HIE grade II
• Hypoglycemia
• Cerebral infarction
• Hyper/hypo natremia
• Drug withdrawal
High risk:
• HIE grade III
• Cerebral malformation
• Kernicterus
• Some IEM
22. Prognosis
Prognosis with drug treatment (long term):
By 12 months, 60-70% will be seizure free. After 2
years of seizure-free period, withdrawal of drugs can
be considered.
Predictive factors for relapse:
• Syndromic epilepsy
• Underlying structural pathology
• Severe prolonged epilepsy before remission
• Increased age